*Syringe-Infusion Pump Compatibility Solutions Workshop

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$1,500,000 to $3,000,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
Not on record
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration is procuring third-party organizational services to develop and facilitate a workshop convening syringe-infusion pump manufacturers to identify critical syringe characteristics affecting pump performance and establish a technical framework for a universal compatibility standard. The workshop will produce a white paper or collaborative document summarizing findings, areas of alignment, and recommendations to reduce syringe-pump incompatibility adverse events and support future standard development. The solicitation is estimated to release on 2026-07-01, with award anticipated on 2027-01-01.

The estimated award value ranges from $1.5 million to $3 million. Inquiries should be directed to the FDA's contracting mailbox at cdhracquisitions@fda.hhs.gov.

Forecast text

OHT3 is proposing to contract a third-party organization to develop and facilitate an FDA-led workshop with manufacturers on syringe-infusion pump compatibility solutions. This workshop would provide a structured forum to convene pump and syringe manufacturers, identify syringe characteristics that critically impact pump performance, and develop a technical framework that will be used to accelerate future development of a universal compatibility standard. A key deliverable would be a white paper (or similar collaborative document) summarizing findings, areas of alignment, and recommendations that will in turn serve as a foundation for further development to protect patients from syringe-pump incompatibility adverse events.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast